Artificial intelligence in the rational design of lipid nanoparticles for mRNA therapeutics
This review surveys how artificial intelligence is converting this nonlinear design space from empirical iteration into data-efficient, multi-objective optimization and outlines three priorities for translation: standardized data and metadata, mechanistic endpoints for escape and immunogenicity, and CMC-aware optimization.